NOVEL METHOD
There is provided inter alia according to the invention an ex vivo method of obtaining tolerogenic antigen presenting cells (APCs) that have the capability to induce tolerance in the immune system to an antigen, the method comprising (a) isolating monocytes from a sample obtained from a mammal; and...
Saved in:
Main Authors | , , , |
---|---|
Format | Patent |
Language | English French |
Published |
17.06.2021
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | There is provided inter alia according to the invention an ex vivo method of obtaining tolerogenic antigen presenting cells (APCs) that have the capability to induce tolerance in the immune system to an antigen, the method comprising (a) isolating monocytes from a sample obtained from a mammal; and (b) culturing the isolated monocytes in a cell culture to induce differentiation of the monocytes into antigen presenting cells having a tolerogenic phenotype, wherein the cell culture comprises (i) retinoic acid and TGFbeta, (ii) retinoic acid, TGFbeta and an AhR agonist or (iii) retinoic acid and an AhR agonist.
Entre autres, l'invention concerne un procédé ex vivo d'obtention de cellules présentatrices d'antigène tolérogènes (CPA) qui ont la capacité d'induire une tolérance dans le système immunitaire à un antigène, le procédé comprenant (a) l'isolement de monocytes à partir d'un échantillon obtenu à partir d'un mammifère ; et (b) la culture des monocytes isolés dans une culture cellulaire pour induire la différenciation des monocytes en cellules présentatrices d'antigène ayant un phénotype tolérogène, la culture cellulaire comprenant (i) l'acide rétinoïque et le TGFbeta , (ii) L'acide rétinoïque, le TGFbeta et un agoniste AhR ou (iii) l'acide rétinoïque et un agoniste AhR. |
---|---|
AbstractList | There is provided inter alia according to the invention an ex vivo method of obtaining tolerogenic antigen presenting cells (APCs) that have the capability to induce tolerance in the immune system to an antigen, the method comprising (a) isolating monocytes from a sample obtained from a mammal; and (b) culturing the isolated monocytes in a cell culture to induce differentiation of the monocytes into antigen presenting cells having a tolerogenic phenotype, wherein the cell culture comprises (i) retinoic acid and TGFbeta, (ii) retinoic acid, TGFbeta and an AhR agonist or (iii) retinoic acid and an AhR agonist.
Entre autres, l'invention concerne un procédé ex vivo d'obtention de cellules présentatrices d'antigène tolérogènes (CPA) qui ont la capacité d'induire une tolérance dans le système immunitaire à un antigène, le procédé comprenant (a) l'isolement de monocytes à partir d'un échantillon obtenu à partir d'un mammifère ; et (b) la culture des monocytes isolés dans une culture cellulaire pour induire la différenciation des monocytes en cellules présentatrices d'antigène ayant un phénotype tolérogène, la culture cellulaire comprenant (i) l'acide rétinoïque et le TGFbeta , (ii) L'acide rétinoïque, le TGFbeta et un agoniste AhR ou (iii) l'acide rétinoïque et un agoniste AhR. |
Author | POOL, LIENEKE ENGLEZOU, PAVLOS WIGREN, MARIA ROMEDAHL, HANNE |
Author_xml | – fullname: ENGLEZOU, PAVLOS – fullname: POOL, LIENEKE – fullname: WIGREN, MARIA – fullname: ROMEDAHL, HANNE |
BookMark | eNrjYmDJy89L5WTg8fMPc_VR8HUN8fB34WFgTUvMKU7lhdLcDApuriHOHrqpBfnxqcUFicmpeakl8c6OxoZmxiYWZo6GxkQoAQAJzB2a |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
DocumentTitleAlternate | NOUVEAU PROCEDE |
ExternalDocumentID | CA3163486A1 |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_CA3163486A13 |
IEDL.DBID | EVB |
IngestDate | Fri Aug 30 05:45:57 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English French |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_CA3163486A13 |
Notes | Application Number: CA20203163486 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210617&DB=EPODOC&CC=CA&NR=3163486A1 |
ParticipantIDs | epo_espacenet_CA3163486A1 |
PublicationCentury | 2000 |
PublicationDate | 20210617 |
PublicationDateYYYYMMDD | 2021-06-17 |
PublicationDate_xml | – month: 06 year: 2021 text: 20210617 day: 17 |
PublicationDecade | 2020 |
PublicationYear | 2021 |
RelatedCompanies | IDOGEN AB |
RelatedCompanies_xml | – name: IDOGEN AB |
Score | 3.3446536 |
Snippet | There is provided inter alia according to the invention an ex vivo method of obtaining tolerogenic antigen presenting cells (APCs) that have the capability to... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPIRITS VINEGAR WINE |
Title | NOVEL METHOD |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210617&DB=EPODOC&locale=&CC=CA&NR=3163486A1 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQsTA2SbQ0NTLTtbAwTNY1ASrStbQwNNM1SrUwMzFIAw3qg8Yhff3MPEJNvCJMI5gYMmF7YcDnhJaDD0cE5qhkYH4vAZfXBYhBLBfw2spi_aRMoFC-vVuIrYsatHdsBOrgmKu5ONm6Bvi7-DurOTvbOjuq-QXZGgPbHSYWZo7AjhIrqBUNOmbfNcwJtCmlALlGcRNkYAsAGpZXIsTAlJonzMDpDLt4TZiBwxc63w1kQrNesQgDj59_mKuPgq9riIe_iyiDgptriLOHLtDYeLgX4p0d4Q4wFmNgAfbsUyUYFAwsU5KAzackM1C3xiI5ycLMOMXU3CDJ0szEMMki2USSQRKnMVJ45KQZuEBhAVrRZGguw8BSUlSaKgusO0uS5MC-BgBwum6s |
link.rule.ids | 230,309,786,891,25594,76906 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8NAEB5KFStetCrWZw6SWzCPzWZzCJJuEqLmUSSW3oKbRuilFhvx7zsb0upFb8vuMuwOzM58s_MAuGUWeXVtk2qMGZVGcJPmMoNqZs0o0d-kU1_6IdOMxi_kcWbPerDY5MK0dUK_2uKIKFEVynvTvterHydW0MZWru_EAqfe76PCC9QOHZsS4DhqMPbCSR7kXOXc476aPXsW2h2EUR-B0o4ji_NKy2k6lkkpq98aJTqE3QkSWzZH0KuXQxjwTeO1Ieyl3X83DjvRWx_DQZZPw0RJwyLOgxNQorDgsYZky-0VSu5vD2CdQh-RfX0Giu7OBZpPgkpYwyrBqDW3HV24lBiCVWQEoz_JnP-zdgODuEiTMnnIni5gX_JFRjcZziX0m4_P-gr1aCOuWw58A8TocZk |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=NOVEL+METHOD&rft.inventor=ENGLEZOU%2C+PAVLOS&rft.inventor=POOL%2C+LIENEKE&rft.inventor=WIGREN%2C+MARIA&rft.inventor=ROMEDAHL%2C+HANNE&rft.date=2021-06-17&rft.externalDBID=A1&rft.externalDocID=CA3163486A1 |